Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Immunohistochemical Staining With Neuroendocrine Markers is Essential in the Diagnosis of Neuroendocrine Neoplasms of the Esophagogastric Junction

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Archival bone marrow samples: suitable for multiple biomarker analysis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Differential Expression of miR-155 and miR-21 in Tumor and Stroma Cells in Diffuse Large B-Cell Lymphoma

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Increase of Ki-67 index and influence on mortality in patients with neuroendocrine neoplasms

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. A short report of 50 patients with gastroenteropancreatic mixed neuroendocrine-non-neuroendocrine neoplasms (MiNEN)

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Neuroendocrine neoplasms (NENs) of the esophagogastric junction (EGJ) are uncommon and the classification of these tumors has been revised several times. Since 2016, at the Department of Pathology, Rigshospitalet, Denmark, all adenocarcinomas and poorly differentiated carcinomas of the EGJ have been stained routinely with the neuroendocrine markers, synaptophysin and chromogranin A, to detect a possible neuroendocrine component. This study aimed to determine if routine immunohistochemical staining is necessary to detect neuroendocrine differentiation of the EGJ tumors by evaluating how often a neuroendocrine component of the tumors was correctly identified or missed on routine hematoxylin and eosin-stained slides, and by evaluating the interobserver agreement among several pathologists. Of 262 cases a NEN was identified in 24 (9.2%). Up to 22.7% of all EGJ NENs would have been missed without routinely performed neuroendocrine staining in all EGJ tumors. The interobserver agreement between 3 pathologists was slight to moderate. In conclusion, immunohistochemical staining with neuroendocrine markers is essential for the diagnosis of NENs, and to detect all NENs, we recommend to perform this routinely on all resected tumors of the EGJ.

Original languageEnglish
JournalApplied Immunohistochemistry and Molecular Morphology
Volume29
Issue number6
Pages (from-to)454-461
Number of pages8
ISSN1541-2016
DOIs
Publication statusPublished - 1 Jul 2021

    Research areas

  • neuroendocrine neoplasm, neuroendocrine carcinoma, mixed neuroendocrine-non-neuroendocrine neoplasm, esophagogastric junction, synaptophysin, chromogranin A

ID: 61877660